Clinical trial
Clinical Evaluation of BÜHLMANN Fecal Pancreatic Elastase (fPELA) Tests in the Diagnosis of Exocrine Pancreatic Insufficiency (PEI)
NCT04548778 is registered in ClinicalTrials.gov with Bühlmann Laboratories AG as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Evaluation of BÜHLMANN Fecal Pancreatic Elastase (fPELA) Tests in the Diagnosis of Exocrine Pancreatic Insufficiency (PEI)
- Lead sponsor
- Bühlmann Laboratories AG
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 1, 2020
- Completion date
- September 21, 2024
- Enrollment
- 201 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.